Page 2 - Deepak Chadha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Apr 27, 2021 - - - Topline results for Phase 3 Pivotal Cardigan I and Cardigan II clinical studies expected in Q4 2021 BOULDER, Colo., April 27, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced completion of patient enrollment in the Phase 3 pivotal Cardigan I study and that the Cardigan II study has surpassed 50% enrollment. Both studies are eval...

Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment Efficacy assessments showed a clinically meaningful and sustained improvement in sweat severity through the 48 weeks of treatment Data presented today in a late-breaking oral presentation at AAD VMX 2021 Management to host an investor call today at 12:00 p.m. EDT BOULDER, Colo., April 23, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription ...

Are These Biotech Penny Stocks on Your Watchlist? As April comes to an end, investors are still searching for the best penny stocks to buy. Whether due to the pandemic or not, 2021 has been the year for biotech penny stocks. While Covid had a negative impact on most industries last year, many have since recovered, with some even pushing new all-time highs. And yes, the coronavirus has emphasized biotech penny stocks producing either a vaccine or treatment for SARS-CoV-2. However, we have seen companies working outside of pandemic-related treatments, also rise in value. This increase in attent...

My dad taught me to be the man of my words: Jeevansh Chadha + We serve personalized stories based on the selected cityOK Hello, Subscribe Please enter valid email. Thank you for subscribing!Your subscription is confirmed for latest news across Entertainment, Television and Lifestyle newsletters. My dad taught me to be the man of my words: Jeevansh Chadha Comments () Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil. Be the first one to review. We have sent you a verification email. To v...

Published: Jan 19, 2021 BOULDER, Colo., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that the efficacy and safety results from the pivotal Phase 3 study conducted in Japan by its development partner, Kaken Pharmaceutical Co., Ltd. (“Kaken”) were published in the peer-reviewed Journal of Dermatology 1. The paper, entitled “A phase 3, multicenter, randomized, do...